LUEbeck Registry of Intensive Care Patients - Characterization of the Patients Intestinal MICROBIOME

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04067271

Acronym

LUERIC-M

Enrollment

200

Registered

2019-08-26

Start date

2019-03-18

Completion date

2024-03-18

Last updated

2022-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Patients

Brief summary

The purpose of the current study is to analyze the effects of ICU-care on changes in microbiome and the influence of intestinal microbiome changes on short-term and long-term morbidity and mortality of ICU patients.

Interventions

OTHERAnalyze changes in intestinal microbiome

Descriptive Analysis

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥18 years * All patients receiving intensive medical care * A written informed consent from the patient or two independent doctors or legal guardians.

Exclusion criteria

* Age \<18 years

Design outcomes

Primary

Measure	Time frame	Description
Modification of the microbiome	Day 0	The modification of the microbiome using ribosomal 16 S DNA sequencing and clustering for Operational Taxonomic Units (OTU) and calculated Shannon Index

Secondary

Measure	Time frame	Description
ICU intensive care unit stay	Day 0	Duration
Hospital stay	Month 12	Duration
Survival	Month 6	To discharge

Countries

Germany

Contacts

Primary ContactTobias Graf, MD

tobias.graf@uksh.de+49 451 500 75306

Backup ContactRoza Meyer-Saraei, PhD

roza.meyer-saraei@uksh.de+49 451 500 44542

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026